dronabinol has been researched along with Anxiety Disorders in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Amminger, GP; Berger, M; McGregor, IS | 1 |
| Haycraft, AL | 1 |
| Hernandez, C; Laiteerapong, N; Sawicki, SM; Zahradnik, EK | 1 |
| Limebeer, CL; Mechoulam, R; Parker, LA; Petrie, GN; Rock, EM; Williams, LA | 1 |
| Grieb, M; Lutz, B; Moreira, FA | 1 |
| Cravatt, BF; Kinsey, SG; Lichtman, AH; Long, JZ; O'Neal, ST | 1 |
| Abelson, JL; Angstadt, M; Liberzon, I; Milad, MR; Phan, KL; Rabinak, CA; Sripada, CS | 1 |
| Mechoulam, R; Parker, LA | 1 |
| Nomikos, GG; Tzavara, ET; Witkin, JM | 1 |
| Grotenhermen, F | 1 |
| Koethe, D; Leweke, FM | 1 |
5 review(s) available for dronabinol and Anxiety Disorders
| Article | Year |
|---|---|
Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression.
Topics: Affect; Animals; Anxiety Disorders; Cannabinoid Receptor Modulators; Depressive Disorder; Dronabinol; Humans; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2009 |
The endocannabinoid system and the brain.
Topics: Animals; Anxiety Disorders; Brain; Cannabinoids; Cannabis; Cognition; Depressive Disorder; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Humans; Learning; Memory; Neurogenesis; Receptors, Cannabinoid; Reward | 2013 |
A role for cannabinoid CB1 receptors in mood and anxiety disorders.
Topics: Affect; Animals; Anxiety Disorders; Cannabinoid Receptor Modulators; Dronabinol; Humans; Models, Animal; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1 | 2005 |
Cannabinoids.
Topics: Animals; Anxiety Disorders; Cannabidiol; Cannabinoid Receptor Modulators; Cannabinoids; Dronabinol; Drug Evaluation; Drug Evaluation, Preclinical; Humans; Psychotropic Drugs; Receptors, Cannabinoid | 2005 |
Cannabis and psychiatric disorders: it is not only addiction.
Topics: Affect; Animals; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Brain; Cannabinoid Receptor Modulators; Cannabinoids; Cognition Disorders; Depressive Disorder, Major; Dronabinol; Drug Interactions; Humans; Marijuana Abuse; Mood Disorders; Psychoses, Substance-Induced; Receptor, Cannabinoid, CB1; Risk Factors; Schizophrenia; Signal Transduction | 2008 |
1 trial(s) available for dronabinol and Anxiety Disorders
| Article | Year |
|---|---|
Cannabinoid facilitation of fear extinction memory recall in humans.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Cannabinoid Receptor Agonists; Cannabinoids; Double-Blind Method; Dronabinol; Extinction, Psychological; Fear; Female; Galvanic Skin Response; Humans; Male; Memory, Episodic; Mental Recall; Middle Aged; Molecular Targeted Therapy; Nootropic Agents; Young Adult | 2013 |
5 other study(ies) available for dronabinol and Anxiety Disorders
| Article | Year |
|---|---|
Medicinal cannabis for the treatment of anxiety disorders.
Topics: Analgesics; Anxiety Disorders; Cannabidiol; Cannabis; Dronabinol; Humans; Medical Marijuana | 2022 |
Cannabis update: Anxiety disorders and post-traumatic stress disorder.
Topics: Adult; Anxiety Disorders; Cannabidiol; Cannabis; Dronabinol; Humans; Medical Marijuana; Stress Disorders, Post-Traumatic | 2023 |
The Use of Dispensary-Obtained Tetrahydrocannabinol as a Treatment for Neuropsychiatric Symptoms of Dementia.
Topics: Aged; Antipsychotic Agents; Anxiety; Anxiety Disorders; Dementia; Dronabinol; Humans | 2023 |
Effect of prior foot shock stress and Δ
Topics: Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Male; Rats; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin 5-HT1 Receptor Antagonists | 2017 |
Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.
Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety Disorders; Benzodioxoles; Cannabinoid Receptor Modulators; Diazepam; Disease Models, Animal; Dronabinol; Endocannabinoids; Enzyme Inhibitors; Male; Mice; Mice, Inbred C57BL; Monoacylglycerol Lipases; Obsessive-Compulsive Disorder; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2011 |